{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:47Z","timestamp":1778739287661,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":188,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["203067514"],"award-info":[{"award-number":["203067514"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["203361917"],"award-info":[{"award-number":["203361917"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.vaccine.2025.128166","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:56:33Z","timestamp":1771336593000},"page":"128166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["Evaluating the broader impact of improved influenza vaccines: A full value of vaccine assessment approach"],"prefix":"10.1016","volume":"60","author":[{"given":"Adam","family":"Soble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuki","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Taaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"Procter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Malvolti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshanna","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naor","family":"Bar-Zeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.vaccine.2025.128166_bb0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017","volume":"7","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128166_bb0015","first-page":"185","article-title":"Vaccines against influenza WHO position paper \u2013 may 2022","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/irv.12488","article-title":"National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya, 2012-2014","volume":"12","author":"Dawa","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"issue":"27","key":"10.1016\/j.vaccine.2025.128166_bb0025","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2025.128166_bb0030","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1016\/j.vaccine.2013.09.013","article-title":"Influenza cost and cost-effectiveness studies globally--a review","volume":"31","author":"Peasah","year":"2013","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2025.128166_bb0035","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1016\/j.vaccine.2015.10.066","article-title":"A systematic review of the social and economic burden of influenza in low- and middle-income countries","volume":"33","author":"de Francisco","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128166_bb0040","article-title":"CDC seasonal flu vaccine effectiveness studies","year":"2024","journal-title":"Ctr Dis Control Prev"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128166_bb0045","article-title":"Estimation of reduction in influenza vaccine effectiveness due to egg-adaptation changes-systematic literature review and expert consensus","volume":"9","author":"Ortiz de Lejarazu-Leonardo","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128166_bb0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.128166_bb0055","series-title":"Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over","year":"2020"},{"issue":"26","key":"10.1016\/j.vaccine.2025.128166_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126274","article-title":"Seasonal influenza vaccination: a global review of national policies in 194 WHO member states in 2022","volume":"42","author":"Goldin","year":"2024","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128166_bb0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.vaccine.2019.11.025","article-title":"Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic","volume":"38","author":"Porter","year":"2020","journal-title":"Vaccine"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2025.128166_bb0075","article-title":"Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine introduction: a global qualitative analysis","volume":"42","author":"Volkmann","year":"2024","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128166_bb0080","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.vaccine.2011.11.092","article-title":"Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean","volume":"30","author":"Ropero-\u00c1lvarez","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128166_bb0085","series-title":"Global influenza strategy 2019\u20132030","year":"2019"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128166_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128166_bb0100","author":"Group TS-AVSP"},{"key":"10.1016\/j.vaccine.2025.128166_bb0105","author":"Team IRD"},{"issue":"26","key":"10.1016\/j.vaccine.2025.128166_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126408","article-title":"Advancing influenza vaccines: a review of next-generation candidates and their potential for global health impact","volume":"42","author":"Taaffe","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-023-02830-w","article-title":"Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study","volume":"21","author":"Waterlow","year":"2023","journal-title":"BMC Med"},{"issue":"41","key":"10.1016\/j.vaccine.2025.128166_bb0120","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1016\/j.vaccine.2023.08.031","article-title":"The potential cost-effectiveness of next generation influenza vaccines in England and Wales: a modelling analysis","volume":"41","author":"Waterlow","year":"2023","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2025.128166_bb0125","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1016\/j.vaccine.2023.10.047","article-title":"The need and ongoing efforts to understand the full value of improved influenza vaccines","volume":"41","author":"Bresee","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-023-02929-0","article-title":"The full value of vaccine assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making","volume":"21","author":"Hutubessy","year":"2023","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128166_bb0135","article-title":"The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations","volume":"12","author":"White","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128166_bb0145","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1016\/S2214-109X(23)00045-1","article-title":"The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study","volume":"11","author":"Clark","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004155","article-title":"The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modeling study","volume":"20","author":"Portnoy","year":"2023","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128166_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004252","article-title":"The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: a modeling study","volume":"20","author":"Portnoy","year":"2023","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128166_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012466","article-title":"The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries","volume":"8","author":"Portnoy","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41541-023-00758-z","article-title":"The full health, economic, and social benefits of prospective strep a vaccination","volume":"8","author":"Cadarette","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41541-023-00646-6","article-title":"Optimal global spending for group A Streptococcus vaccine research and development","volume":"8","author":"Tortorice","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.128166_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104864","article-title":"Antibiotic consumption for sore throat and the potential effect of a vaccine against group a Streptococcus: a systematic review and modelling study","volume":"98","author":"Miller","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41541-023-00668-0","article-title":"Modeling the potential health impact of prospective Strep A vaccines","volume":"8","author":"Giannini","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128166_bb0190","article-title":"An application of an initial full value of vaccine assessment methodology to measles-rubella MAPs for use in low- and middle-income countries","volume":"12","author":"Ko","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128166_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2471\/BLT.23.290163","article-title":"Reassessing potential economic value and health impact of effective Shigella vaccines","volume":"102","author":"Hausdorff","year":"2024","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2025.128166_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127233","article-title":"Identification and sizing of the current use cases for seasonal influenza vaccines","author":"Soble","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128166_bb0205","series-title":"Global vaccine market report 2024","year":"2024"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128166_bb0210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.vaccine.2008.10.069","article-title":"Forecasting demand for Hib-containing vaccine in the world\u2019s poorest countries: a 4-year prospective experience","volume":"27","author":"Zuber","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128166_bb0215","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4161\/hv.6.9.12587","article-title":"Forecasting dengue vaccine demand in disease endemic and non-endemic countries","volume":"6","author":"Amarasinghe","year":"2010","journal-title":"Hum Vaccin"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128166_bb0220","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128166_bb0225","series-title":"Data from: WHO\/UNICEF Joint Reporting Form on Immunization (JRF)","year":"2025"},{"key":"10.1016\/j.vaccine.2025.128166_bb0230","series-title":"Centers for Medicare & Medicaid Services","author":"Vaccine Pricing","year":"2025"},{"key":"10.1016\/j.vaccine.2025.128166_bb0235","article-title":"CDC Vaccine Price List Archives","author":"VFC","year":"2024","journal-title":"US Ctr Dis Control Prev"},{"key":"10.1016\/j.vaccine.2025.128166_bb0240","series-title":"Data from: MI4A Vaccine Purchase Database","year":"2024"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128166_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015837","article-title":"Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand: a modelling study","volume":"9","author":"Procter","year":"2024","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2025.128166_bb0250","article-title":"WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment, Rosalind M Eggo, Mark Jit. The potential global impact and cost-effectiveness of next-generation influenza vaccines: a modelling analysis","author":"Lucy Goodfellow","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.vaccine.2025.128166_bb0255","series-title":"Discounted cash flow methods. In: Investment appraisal","author":"G\u00f6tze","year":"2015"},{"key":"10.1016\/j.vaccine.2025.128166_bb0260","series-title":"Universal influenza vaccine technology landscape [online database]. Minneapolis: Regents of the University of Minnesota","year":"2025"},{"issue":"10261","key":"10.1016\/j.vaccine.2025.128166_bb0270","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","article-title":"Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (\u226565 years): two multicentre, randomised phase 3 trials","volume":"396","author":"Ward","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.128166_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128455","article-title":"The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling study","author":"Goodfellow","year":"2025","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.128166_bb0280","article-title":"Priority setting for improved influenza vaccines: a multi-criteria decision analysis","volume":"60","author":"Federici","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128166_bb0285","series-title":"Full Value of improved Influenza Vaccine Assessment (FVIVA)","year":"2025"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:48:21Z","timestamp":1778737701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":52,"alternative-id":["S0264410X25014641"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128166","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the broader impact of improved influenza vaccines: A full value of vaccine assessment approach","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128166"}}